159 related articles for article (PubMed ID: 22038539)
1. A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3.
Kim DS; Park JH; Kim JY; Kim D; Nam JH
Virus Genes; 2012 Apr; 44(2):176-82. PubMed ID: 22038539
[TBL] [Abstract][Full Text] [Related]
2. An ITAM in a nonenveloped virus regulates activation of NF-κB, induction of beta interferon, and viral spread.
Stebbing RE; Irvin SC; Rivera-Serrano EE; Boehme KW; Ikizler M; Yoder JA; Dermody TS; Sherry B
J Virol; 2014 Mar; 88(5):2572-83. PubMed ID: 24352448
[TBL] [Abstract][Full Text] [Related]
3. Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.
Sun H; Xu XY; Tian XL; Shao HT; Wu XD; Wang Q; Su X; Shi Y
Immunobiology; 2014 Jan; 219(1):25-36. PubMed ID: 23886693
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
[TBL] [Abstract][Full Text] [Related]
5. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.
Stadnick E; Dan M; Sadeghi A; Chantler JK
J Virol; 2004 Dec; 78(24):13987-4002. PubMed ID: 15564506
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.
Park JH; Kim DS; Cho YJ; Kim YJ; Jeong SY; Lee SM; Cho SJ; Yun CW; Jo I; Nam JH
Vaccine; 2009 Mar; 27(13):1974-83. PubMed ID: 19168108
[TBL] [Abstract][Full Text] [Related]
7. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva.
Henke A; Nestler M; Strunze S; Saluz HP; Hortschansky P; Menzel B; Martin U; Zell R; Stelzner A; Munder T
Virology; 2001 Oct; 289(1):15-22. PubMed ID: 11601913
[TBL] [Abstract][Full Text] [Related]
8. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
Wang Y; Pfeiffer JK
mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
[TBL] [Abstract][Full Text] [Related]
9. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
[TBL] [Abstract][Full Text] [Related]
10. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
11. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.
Dan M; Chantler JK
J Virol; 2005 Jul; 79(14):9285-95. PubMed ID: 15994822
[TBL] [Abstract][Full Text] [Related]
12. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
13. Tyrosines in the carboxyl terminus regulate Syk kinase activity and function.
de Castro RO; Zhang J; Jamur MC; Oliver C; Siraganian RP
J Biol Chem; 2010 Aug; 285(34):26674-84. PubMed ID: 20554527
[TBL] [Abstract][Full Text] [Related]
14. Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis.
Bao J; Sun T; Yue Y; Xiong S
Mol Immunol; 2019 Oct; 114():41-48. PubMed ID: 31336248
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.
Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC
Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.
Huber SA; Polgar J; Schultheiss P; Schwimmbeck P
J Virol; 1994 Jan; 68(1):195-206. PubMed ID: 8254729
[TBL] [Abstract][Full Text] [Related]
18. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact.
Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.
Esfandiarei M; Luo H; Yanagawa B; Suarez A; Dabiri D; Zhang J; McManus BM
J Virol; 2004 Apr; 78(8):4289-98. PubMed ID: 15047842
[TBL] [Abstract][Full Text] [Related]
20. Downstream signaling molecules bind to different phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) peptides of the high affinity IgE receptor.
Kimura T; Kihara H; Bhattacharyya S; Sakamoto H; Appella E; Siraganian RP
J Biol Chem; 1996 Nov; 271(44):27962-8. PubMed ID: 8910399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
